PubMed Health⌕ Search

Biomedical subjects

G L Spaeth

Publications and source records attributed to G L Spaeth.

At least 91 records · Page 5Linked to original sources
PubMed1993

Methazolamide-induced skin eruptions.

To our knowledge, this is the first histopathologic report of skin eruptions due to oral methazolamide. From the four cases studied, we conclude that there are at least two histopathologic types: one is characterized by perivascular lymphocytic infiltrate with a vacuolar alteration at the dermoepidermal junction, the other by perivascular eosinophils, lymphocytes, and scattered mast cells. There also seem to be at least two patterns of skin eruptions: one maculopapular and the other urticarial. The type of skin eruption and the histopathologic type appear to be related.

Administration, Oral↗
PubMed1993

Brimonidine in the prevention of intraocular pressure elevation following argon laser trabeculoplasty.

OBJECTIVE: To evaluate the efficacy of 0.5% brimonidine tartrate, an alpha 2-adrenergic agonist, in preventing intraocular pressure (IOP) elevation following argon laser trabeculoplasty. DESIGN: In a multicenter, double-masked, randomized study, 248 patients (248 eyes) who underwent argon laser trabeculoplasty were allocated to four treatment groups: (1) brimonidine administered before and after the procedure; (2) brimonidine administered before the procedure; (3) brimonidine administered after the procedure; and (4) a vehicle administered before and after the procedure. RESULTS: In the first 3 hours after argon laser trabeculoplasty, only one (0.54%) of the 183 brimonidine-treated patients had a postlaser IOP increase of 10 mm Hg or more, while increases of this magnitude occurred in 13 (23%) of the 56 patients who received only the vehicle (P < .001). The three brimonidine-treatment groups demonstrated significant mean reductions in IOP from the pretrabeculoplasty level (-4 to -8 mm Hg), whereas the vehicle-treated group showed an increase in mean IOP (4 mm Hg). Side effects associated with brimonidine treatment included conjunctival blanching (40.9%), lid retraction (7.6%), and a slight lowering of the systolic blood pressure. CONCLUSIONS: One drop of 0.5% brimonidine administered either before or after surgery was found to be efficacious and safe in preventing posttrabeculoplasty elevations in IOP.

Adrenergic alpha-Agonists↗
PubMed1993

Primary trabeculectomy in young adults.

BACKGROUND: Younger patients are thought to have a poor surgical prognosis after trabeculectomy. The authors investigate the surgical outcome of young adult patients after primary trabeculectomy. METHODS: The authors reviewed the charts of all patients 15 to 40 years of age who had undergone primary trabeculectomy without the use of antimetabolites between January 1985 and January 1992 at Wills Eye Hospital. Failure was defined before the data collection as intraocular pressure (IOP) more than 25 mmHg without medication, IOP more than 21 mmHg with medication, or when further glaucoma surgery was indicated. Patients in whom preoperative IOPs were 21 mmHg or lower were classified as successes when the IOP was reduced by at least 33% of the preoperative measurement. RESULTS: After a mean follow-up of 36.8 +/- 21.8 months, among the 31 patients with uncomplicated glaucomas (juvenile, pigmentary, low tension, chronic angle closure), 26 (83.9%) were considered successes. After a mean follow-up of 42.3 +/- 26.5 months, among the 11 patients with other types of glaucoma (inflammatory, traumatic, associated with irido-corneal endothelial syndrome or mesodermal dysgenesis), 7 (63.6%) were considered successes. CONCLUSIONS: The success rate of the uncomplicated group compares favorably with the 75% to 90% success rates of trabeculectomy commonly cited for primary glaucomas in older patients. Primary trabeculectomy in young adults may have a favorable outcome despite no antimetabolite therapy.

Adolescent↗
PubMed1993

Loss of visual acuity after trabeculectomy.

BACKGROUND: Glaucoma filtration surgery can result in loss of visual acuity by a variety of mechanisms. The existence of "wipe-out" (loss of the central visual field in the absence of other explanation) as a cause of postoperative loss of visual acuity has been debated. This study defines the incidence and etiology of visual acuity loss within 3 months of trabeculectomy. METHODS: The authors reviewed 508 eyes of 440 patients who underwent trabeculectomy to find cases of postoperative visual acuity loss (2 or more Snellen lines or a category change) and randomly selected a control group of 85 eyes to analyze the risk factors for each cause of visual acuity loss. RESULTS: Forty-two eyes (8.3%) showed loss of visual acuity after 3 months, caused mainly by lens opacification (n = 16), hypotony maculopathy (n = 6), and "wipe-out" (n = 4). Older patients (P = 0.0108), those in whom the visual field preoperatively showed macular splitting (P = 0.0084) and those who had severe hypotony (intraocular pressure [IOP] < or = 2 mmHg) on the first postoperative day (P = 0.0246) were more likely to experience "wipe-out." Older age (P = 0.0495) and shallow anterior chamber (P = 0.0003) were correlated to the development of lens opacification. Hypotony maculopathy was associated with coronary artery disease (P = 0.0397) and systemic hypertension (P = 0.0118). CONCLUSIONS: Lens opacification was the main cause of early visual acuity loss after trabeculectomy, followed by hypotony maculopathy. "Wipe-out," although rare, does exist, and older patients with advanced visual field defects are at increased risk.

Age Factors↗
PubMed1993

The influence of primary open-angle glaucoma upon the retrobulbar circulation: baseline, postoperative and reproducibility analysis.

CDI is showing continued promise as a reliable, reproducible method to assess the hemodynamics of a variety of ophthalmic diseases in which vascular perfusion abnormalities are suspect. Moreover, some patients with advanced POAG appears to have abnormalities of the vasculature of the retrobulbar circulation that is corrected by trabeculectomy. Continued CDI clinical correlations with longitudinal studies are now required to elucidate the significance of this technology and these results for individual patients.

Adult↗
PubMed1993

Focal and diffuse visual field defects: their relationship to intraocular pressure.

The view that visual field loss in "low-tension" glaucoma (LTG) is more focal than in ordinary or "high-tension" glaucoma (HTG) is controversial. The basis of the controversy may be the inappropriate presupposition that an arbitrary intraocular pressure (IOP) level effectively differentiates these entities. We attempted to determine whether meaningful differences exist between glaucoma patients classified on the basis of pattern of visual field loss rather than IOP. One hundred consecutive glaucomatous visual fields were classified as focal or diffuse by two independent observers masked to all other clinical information. Several clinical parameters were then evaluated, comparing patients with focal visual field loss, with those with diffuse loss. Maximal pretreatment IOP was significantly lower among the patients with focal visual field loss than it was among those with diffuse loss (21.5 mm Hg +/- 5.7 vs 25.9 mm Hg +/- 4.7; P < .01). There was no difference between the two groups in terms of age, blood pressure, visual acuity, or color vision. We conclude that focal glaucomatous visual field loss occurs at a lower IOP than diffuse loss and, as such, may be a marker by which to identify patients whose optic nerves are abnormally susceptible to glaucomatous injury.

Aged↗
PubMed1993

106 years later.

Explore the source record for details and available documents.

Education, Nursing↗